The table below shows TANDEM DIABETES CARE INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$9.72M
$24.23M
-$31.81M
$50.46M
$111.36M
$24.67M
Capital expenditure
$19.95M
$19.23M
$26.80M
$34.10M
$14.18M
$27.41M
Investing cash flow
$72.88M
-$23.48M
-$85.74M
$33.17M
-$186.88M
-$296.06M
Dividends paid
-
-
-
-
-
TNDM operating cash flow (10-K history)
TANDEM DIABETES CARE INC reported operating cash flow of -$9.72M for fiscal year 2025. That is down 140.1% from $24.23M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$61.17M (FY 2016) to -$9.72M. Figures come from the company's audited annual reports as filed with the SEC.
